Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab.
Saved in:
| Title: | Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab. |
|---|---|
| Authors: | Zhu C; Department of Dermatology, Fujian Medical University Union Hospital, Fuzhou, China., Fok JS; Department of Respiratory Medicine and General Medicine, Box Hill Hospital, Eastern Health, Victoria, Australia.; Allergy/Immunology, Monash Medical Centre, Monash Health, Victoria, Australia., Lin L; Department of Dermatology, Fujian Medical University Union Hospital, Fuzhou, China., Su H; Department of Dermatology, Fujian Medical University Union Hospital, Fuzhou, China., Maurer M; Institute of Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany. |
| Source: | JAAD case reports [JAAD Case Rep] 2022 Dec 28; Vol. 32, pp. 109-112. Date of Electronic Publication: 2022 Dec 28 (Print Publication: 2023). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101665210 Publication Model: eCollection Cited Medium: Print ISSN: 2352-5126 (Print) Linking ISSN: 23525126 NLM ISO Abbreviation: JAAD Case Rep Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2352-5126 |
|---|---|
| DOI: | 10.1016/j.jdcr.2022.12.009 |
